One of the challenges in the exciting and rapidly growing field of regenerative medicine is the production of biomaterials that closely mimic the body’s own matrix. Gelatin fits this profile and is highly favored in this segment. X-Pure gelatins and collagens add a new quality aspect: exceptionally low endotoxin levels.
In designing parenteral products such as vaccines, limiting exposure of the body to endotoxins is crucial. With X-pure 10 HGP we offer an excipient that is purer than most gelatin alternatives available on the market today.
Every year, five million people die from blood loss, mainly during surgery. Gelatin-based hemostatic products are widely used to stop the bleeding and promote clotting in the operating theater. Our X-Pure acid gelatin range provides an exceptionally safe solution for in-body hemostatic use.
As the most recent strategic segment within Rousselot, we have drawn upon Rousselot’s 125+ years of worldwide expertise and proven track record of pharmaceutical gelatins and collagens to develop X-Pure®, an innovative range of purified gelatins and collagens specifically designed for (bio)medical applications. Offering unique advantages to assure performance, quality and safety, X-Pure is backed by strong scientific data and on-going research. Rousselot Biomedical is committed to facilitating the use of X-Pure in your applications and to help advancing medical science and clinical therapies.
Endotoxins have been shown to negatively affect cell viability, proliferation and to alter stem cell differentiation. It’s therefore important to control the endotoxin levels during cell culturing.
Watch our video explaining how Rousselot X-Pure answers this requirement.
Video hosted on YouTube
X-pure is a range of gelatins and collagens designed for biopharmaceutical partners engaged in regenerative medicine and drug screening and development, as well as hemostatic and parenteral applications.
Biomedical , Health , _News Rousselot , rousselot